Glassia Injection, Solution
Product Images NDC 0944-2884

This is a description of a medication called Glassia. It is made by the company Ronly Giseiaprocuct of Seigum and marketed by Takeda Pharmaceuticals USA, Inc. The medication is an injection solution containing 2% active alpha-1 proteinase inhibitor [human] used for intravenous administration. The package includes one single-use vial of 50 ml Glassia and one sterile single-use filter needle. The contents of the injection solution are 0.2 M Sodium Phosphate. Please refer to the package insert for dosage information.*

This is a description of a medication called Alpha-1 Proteinase Inhibitor intended for intravenous administration only. The medication is stored in a single-use vial that should be preserved at a temperature range of 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit). It must not be frozen, and any unused contents should be discarded. The product should be brought to room temperature within three hours of entering the vials before being administered according to the dosage information outlined in the package insert. The medication contains 2% active Alpha-1 proteinase inhibitor, 0.02M sodium phosphate, 0.7% sodium chloride, water for injection, and is manufactured by Takeda Pharmaceuticals USA, Inc. NDC Code: 0944-2884-02.*